PHARMATECA » Search Articles by Keyword
Found: 7 articles
Article |
Edition |
Bagdasaryan A.A., Shikh E.V., Drozdov V.N.
The influence of CYP3A5, CYP2D6, CYP2C19 and ABCB1 gene polymorphisms on the levels of minimum steady-state concentration of doxorubicin and troponin I in patients with breast cancer: an observational cross-sectional study
|
№9 / 2024
|
Xinyi Yang, Reshetov I.V., Poltavskaya M.G., Agakina Yu.S., Kulikov T.S.
Studying on the progress of cardiotoxicity induced by PD-1/PD-L1 immune checkpoint inhibitors
|
№9 / 2024
|
I.N. Cherezova, N.Kh. Gabitova, I.V. Osipova
Cardiotoxicity of doxorubicin in a child with acute leukemia
|
№7 / 2024
|
Z.T. Astakhova, M.T. Zaseeva
Cardiotoxicity and chronic heart failure in the treatment of patients with gastric cancer: pathogenesis, methods of prevention and therapy
|
№7 / 2024
|
Sayapina M.S.
Doxorubicin and toxicity
|
№4 / 2024
|
L.R. Bogatyreva, N.S. Besova, G.S. Yunaev, I.A. Kurmukov, E.S. Obarevich, D.A. Gavrilova, A.V. Egorova, N.V. Lepkova, A.A. Tryakin
Cardiac toxicity of fluoropyrimidines in the treatment of solid gastrointestinal tumors
|
№6-7 / 2023
|
E.A. Kolomiets, N.S. Besova, I.A. Kurmukov, Sh.R. Kashia, M.N. Narimanov, A.P. Sandomirskaya
CARDIOVASCULAR TOXICITY OF FLUOROPIRYMIDINES
|
№18 / 2017
|
{"loading":"Loading...","close":"Close","yes":"Yes","no":"No","proceed":"Proceed","conf_del":"Do you really want to delete","cancel":"Cancel"}